Key Highlights
- Rivian shares declined approximately 4% in premarket trading Friday following Q1 earnings release, outperforming analyst loss projections
- First-quarter revenue reached $1.38B, representing an 11% year-over-year increase; loss per share of $0.33 significantly outperformed the $0.72 analyst consensus
- R2 manufacturing has commenced at the Normal, IL facility; customer deliveries scheduled for “later this spring”
- DOE financing reduced from $6.6B to approximately $4.5B, while Georgia manufacturing facility capacity expanded 50% to 300,000 vehicles
- A skeptical investor maintains RIVN carries excessive valuation at $20B market capitalization given unproven R2 consumer demand
Rivian shares (RIVN) slipped approximately 4% during premarket hours Friday following the electric vehicle manufacturer’s Q1 2026 financial results. The stock concluded Wednesday’s session at $16.40 before declining to $15.76 in early Friday activity.
The financial performance exceeded analyst projections. Revenue totaled $1.38 billion, marking an 11% year-over-year gain. The $0.33 loss per share significantly outperformed the $0.72 Wall Street consensus estimate.
Rivian recorded gross profit of $119 million — marking the third straight quarter of positive gross profit. The software and services division proved particularly strong, generating $180 million in gross profit, representing nearly 60% growth compared to the prior year period.
Adjusted EBITDA registered a $472 million loss. The company continues operating in the red, a reality investors clearly recognize.
Rivian manufactured 10,236 vehicles and completed deliveries of 10,365 units during Q1. The company maintained its full-year 2026 delivery projection of 62,000 to 67,000 vehicles.
The R2 has entered production at Rivian’s Normal, Illinois manufacturing facility. CEO RJ Scaringe indicated customer deliveries will commence “later this spring,” with the primary volume increase occurring during Q3 and Q4.
“With the increase in volume, you have more fixed cost absorption, so the cost of goods sold will come down meaningfully,” Scaringe explained. “The margin structure will start to shine through.”
Georgia Manufacturing Facility Plans Revised
Rivian announced updated specifications for its forthcoming Georgia assembly facility. Initial production capacity will expand 50% to 300,000 vehicles, with construction launching in 2026.
The DOE financing package supporting the facility has been adjusted downward from $6.6 billion to approximately $4.5 billion. Rivian will begin accessing these funds in 2027, ahead of the previously planned 2028 timeframe.
“Accessing those dollars sooner and faster is going to be helpful to get more capacity, more volume sooner,” Scaringe stated. Following Phase 1 completion, Rivian projects total manufacturing capacity exceeding 500,000 vehicles — a threshold Scaringe identifies as supporting positive free cash flow.
Cash Position Remains Solid While Skepticism Persists
Rivian concluded Q1 with $4.83 billion in cash and $5.39 billion in total liquidity, declining from $6.59 billion at Q4 close. The reduction reflects continued investment as the company expands operations.
Scaringe highlighted a comprehensive liquidity position of $13.6 billion when accounting for the Volkswagen joint venture investment, the Uber agreement, and the DOE financing. Earlier this year, Rivian secured an additional $1 billion from Volkswagen following successful testing of the VW ID.EVERY1, developed using Rivian software and platform architecture.
The Uber partnership, revealed in March, involves Rivian providing up to 50,000 autonomous R2 electric vehicles in return for $1.25 billion in capital.
Skepticism remains among certain investors. ValueAnalyst maintains a Sell rating on RIVN, contending the $20 billion market capitalization already incorporates R2 success — while critical specifications including range and final pricing remain undisclosed. Those metrics will remain unclear until late 2027, while over 11% of outstanding shares face short interest.
Wall Street maintains a Moderate Buy consensus rating, with 10 Buy recommendations, 8 Hold ratings, and 4 Sell ratings. The average 12-month price objective stands at $17.91.
